Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bepotastine Besilate in Acute Allergic Conjunctivitis
NCT00424398Phase 3Completed
- Sponsor
- Bausch + Lomb
- Start
- Feb 2007
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bepotastine in allergic conjunctivitis (AC), sponsored by Bausch + Lomb. Started Feb 2007; status: completed.
02
Drugs
bepotastine
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT00424398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00424398.